• Knock_Knock_Lemmy_In@lemmy.world
    link
    fedilink
    arrow-up
    2
    ·
    edit-2
    9 months ago

    The mortality rate of COVID is closer to 2000 cases in 100k than 26.7.

    Ok. So my post was bait. I specifically chose a statistic of young males and myocarditis.

    As expected you misread and responded quoting all age mortality.

    This was the point I was trying to make. Honest discussions are impossible.

    contraction of COVID raises long term risk of heart issues

    Above a certain age, yes.

    Your link is not focused on young males.
    In the specific case of myocarditis in young males, the Pfizer vaccine is higher risk.

    The herd immunity to grants means that, if you can successfully identify high risk individuals, they’re insulated from transmission by the bulk of the population getting vaccinated.

    True for vaccines in general, but for omicron (the dominant strain when most vaccines were given) transmission rates immediately after infection were the same, whether vaccinated or not.

    So the fear of heart issues is mitigated only when everyone else gets the jab.

    Not empirically true for covid vaccines

    On the other, I think there’s a criticism that we haven’t continued to invest in improvements to the mRNA treatment now that we have a simple panacea.

    Disagree. mRNA is now an accepted tool and is being explored for a huge number of medical applications.

    you can’t keep coming back to the debate table in the middle of a pandemic.

    There was no debate during the pandemic. Any criticism was silenced as being anti vaccine.

    You need to move quickly and confidently,

    In public. But this shouldn’t apply to doctors, scientists and other experts.

    But when we’ve embraced a “cheapest, least economically invasive solution” policy method,

    Cheapest would have been open sourcing the Oxford vaccine. Bill Gates stopped that from happening. “As a CEPI founder he had leverage”

    Because what we really care for, in the US, is economic growth.

    Yes. There is no money in an open source, cost of production vaccine, but there is a LOT of money in future mRNA applications.

    EDIT: Links added.